Get Ready for a Biotech M&A Comeback
RBC Capital, heartened by some billion-dollar-plus deals, sees a new buyout hunger in Big Pharma.
The co-founder of BioNTech believes COVID-19 will stick around, but not be such a threat.
The ride-sharing firm’s plan will be provided by NOW: Pensions and managed by Adecco.
The regulator is also seeking information on a financial misstatement from 2020 that triggered a contribution increase.
The Treasury chief decries stalemate in Congress on spending authority.
The endowments gain 65% and 55.9%, respectively, in what has been a banner year for institutional investors.